GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Geratherm Medical AG (XTER:GME) » Definitions » 5-Year Yield-on-Cost %

Geratherm Medical AG (XTER:GME) 5-Year Yield-on-Cost % : 1.13 (As of Jun. 07, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Geratherm Medical AG 5-Year Yield-on-Cost %?

Geratherm Medical AG's yield on cost for the quarter that ended in Jun. 2023 was 1.13.


The historical rank and industry rank for Geratherm Medical AG's 5-Year Yield-on-Cost % or its related term are showing as below:

XTER:GME' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.47   Med: 1.05   Max: 2.19
Current: 1.13


During the past 13 years, Geratherm Medical AG's highest Yield on Cost was 2.19. The lowest was 0.47. And the median was 1.05.


XTER:GME's 5-Year Yield-on-Cost % is ranked worse than
74.11% of 309 companies
in the Medical Devices & Instruments industry
Industry Median: 2.12 vs XTER:GME: 1.13

Competitive Comparison of Geratherm Medical AG's 5-Year Yield-on-Cost %

For the Medical Devices subindustry, Geratherm Medical AG's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Geratherm Medical AG's 5-Year Yield-on-Cost % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Geratherm Medical AG's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Geratherm Medical AG's 5-Year Yield-on-Cost % falls into.



Geratherm Medical AG 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Geratherm Medical AG is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Geratherm Medical AG  (XTER:GME) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Geratherm Medical AG 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Geratherm Medical AG's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Geratherm Medical AG (XTER:GME) Business Description

Traded in Other Exchanges
Address
Fahrenheitstrasse 1, Geratal, DEU, 99331
Geratherm Medical AG is a Germany-based medical technology company. The firm operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Healthcare Diagnostic segment which generates majority revenue provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. Medical Warming Systems offers solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.
Executives
Dr. Gert Frank Supervisory Board
Christian Frick Board of Directors